BlackRock Health Sciences Trust (NYSE:BME) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?

Shares of BlackRock Health Sciences Trust (NYSE:BME) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $41.39 and traded as high as $43.96. BlackRock Health Sciences Trust shares last traded at $43.91, with a volume of 61,997 shares trading hands.

BlackRock Health Sciences Trust Price Performance

The company’s 50-day moving average is $41.57 and its 200 day moving average is $40.85.

BlackRock Health Sciences Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be given a dividend of $0.2621 per share. This represents a c) annualized dividend and a yield of 7.2%. The ex-dividend date is Tuesday, September 15th.

Institutional Trading of BlackRock Health Sciences Trust

A number of hedge funds have recently modified their holdings of BME. Northwestern Mutual Wealth Management Co. grew its holdings in shares of BlackRock Health Sciences Trust by 285,436.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after buying an additional 4,044,638 shares in the last quarter. 1607 Capital Partners LLC lifted its stake in BlackRock Health Sciences Trust by 49.5% in the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock worth $9,429,000 after acquiring an additional 75,958 shares in the last quarter. Bank of America Corp DE boosted its position in BlackRock Health Sciences Trust by 18.8% during the 3rd quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock worth $8,057,000 after acquiring an additional 34,218 shares during the period. Royal Bank of Canada boosted its position in BlackRock Health Sciences Trust by 13.0% during the 4th quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock worth $6,600,000 after acquiring an additional 18,442 shares during the period. Finally, Invesco Ltd. grew its stake in BlackRock Health Sciences Trust by 7.6% during the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock valued at $8,085,000 after acquiring an additional 15,381 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.